A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

698

Participants

Timeline

Start Date

March 27, 2023

Primary Completion Date

November 20, 2023

Study Completion Date

November 20, 2023

Conditions
Seasonal Influenza
Interventions
BIOLOGICAL

mRNA-1011.1

Sterile liquid for injection

BIOLOGICAL

mRNA-1011.2

Sterile liquid for injection

BIOLOGICAL

mRNA-1012.1

Sterile liquid for injection

BIOLOGICAL

mRNA-1010

Sterile liquid for injection

BIOLOGICAL

mRNA-1010.2

Sterile liquid for injection

BIOLOGICAL

mRNA-1010.3

Sterile liquid for injection

Trial Locations (22)

13850

Meridian Clinical Research, LLC, Vestal

19040

Hatboro Medical Associates / CCT Research, Hatboro

20852

DelRicht Research, Rockville

20877

CenExel CBH, Gaithersburg

29572

Trial Management Associates, LLC, Myrtle Beach

30092

Georgia Clinic / CCT Research, Norcross

33024

CenExel RCA, Hollywood

33173

Suncoast Research Associates, LLC, Miami

33613

CenExel FCR, Tampa

63017

DelRicht Research, Town and Country

63141

Sundance Clinical Research, LLC, St Louis

65807

DelRicht Research, Springfield

68134

Meridian Clinical Research, LLC, Omaha

73013

Tekton Research, Edmond

73160

Tekton Research, Moore

80228

Critical Care, Pulmonary and Sleep Associates / CCT Research, Lakewood

80528

Tekton Research, Fort Collins

84663

Springville Dermatology / CCT Research, Springville

89102

Healor Primary Care, Las Vegas

90805

Long Beach Research Institute, Lakewood

90806

Long Beach Clinical Trials, Long Beach

97330

The Corvallis Clinic, PC, Corvallis

All Listed Sponsors
lead

ModernaTX, Inc.

INDUSTRY